Average Co-Inventor Count = 4.63
ph-index = 4
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bristol-myers Squibb Compnay (16 from 3,684 patents)
2. Universitéde Montreal (7 from 183 patents)
22 patents:
1. 12286426 - Heterocyclic mitochondrial activity inhibitors and uses thereof
2. 11760754 - Heterocyclic mitochondrial activity inhibitors and uses thereof
3. 11696928 - Compounds and use thereof in the expansion of stem cells and/or progenitor cells
4. 9518064 - Imidazothiadiazole and imidazopyridazine derivatives as protease activated receptor 4 (PAR4) inhibitors for treating platelet aggregation
5. 9493456 - Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
6. 9429566 - Assay for inhibitors of CIP/KIP protein degradation
7. 9018395 - Pyrazolopyridine and pyrazolopyrimidine derivatives as melanocortin-4 receptor modulators
8. 8343999 - Thiazolyl compounds useful as kinase inhibitors
9. 8148361 - Kinase inhibitors
10. 8148400 - Thiazolyl compounds useful as kinase inhibitors
11. 7851500 - Aminopyrazole kinase inhibitors
12. 7470713 - Imidazole based kinase inhibitors
13. 7312215 - Benzimidazole C-2 heterocycles as kinase inhibitors
14. 7223757 - Tyrosine kinase inhibitors
15. 7081454 - Tyrosine kinase inhibitors